These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7998283)

  • 1. Milan multicenter experience in 96 liver transplants for hepatitis B virus-related cirrhosis.
    Caccamo L; Belli LS; Mazzaferro V; Colledan M; Alberti A; Regalia E; Fassati LR; Ideo G; Rubino A; Belli L
    Transplant Proc; 1994 Dec; 26(6):3585-7. PubMed ID: 7998283
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
    McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; Dickson RC; Caldwell SH; Pruett TL
    Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunoprophylaxis for hepatitis B virus reinfection after liver transplantation.
    Jeng LB; Lee WC; Yeh DS; Wang CC; Wang KL; Chen SC; Chen MF; Chien RN; Chiu CT; Lin DY
    Transplant Proc; 1994 Aug; 26(4):2243-4. PubMed ID: 8066736
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis.
    McGory R; Ishitani M; Oliveira W; Stevenson W; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1687-8. PubMed ID: 8658840
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B infection and liver cirrhosis: a reappraisal from the Mediterranean area.
    Craxì A; Colombo P; D'Amico G; Di Blasi F; Di Marco V; Magrin S; Maisano S; Politi F; Scalisi I; Spinelli G
    Ann Ist Super Sanita; 1987; 24(2):257-65. PubMed ID: 3453607
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
    Gugenheim J; Crafa F; Fabiani P; Goubaux B; Ouzan D; Mouiel J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
    [No Abstract]   [Full Text] [Related]  

  • 7. The long-term course of chronic hepatitis B.
    Di Marco V; Lo Iacono O; Cammà C; Vaccaro A; Giunta M; Martorana G; Fuschi P; Almasio PL; Craxì A
    Hepatology; 1999 Jul; 30(1):257-64. PubMed ID: 10385664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in patients with cirrhosis of unknown cause (cryptogenic cirrhosis): long-term follow-up.
    Gomez R; Moreno E; Colina F; Castellon C; Gonzalez I; Loinaz C; Garcia I; Lumbreras C; Marcello M
    Transplant Proc; 1995 Aug; 27(4):2299-300. PubMed ID: 7652814
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
    Chu CM; Liaw YF
    Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
    Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection.
    Sagnelli E; Stroffolini T; Mele A; Imparato M; Almasio PL;
    Clin Infect Dis; 2008 Jan; 46(1):110-3. PubMed ID: 18171224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of liver cirrhosis in Italy: results from a multicenter national study.
    Stroffolini T; Sagnelli E; Almasio P; Ferrigno L; Craxì A; Mele A;
    Dig Liver Dis; 2004 Jan; 36(1):56-60. PubMed ID: 14971816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
    Lucena JF; Herrero JI
    An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlimited-term passive immunoprophylaxis after liver transplantation in HBsAg-positive patients.
    Lee SG; Lee YJ; Kwon TW; Park KM; Choi KM; Min PC; Chung YH; Lee YS
    Transplant Proc; 1996 Jun; 28(3):1176-7. PubMed ID: 8658617
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft.
    Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1714-6. PubMed ID: 8658852
    [No Abstract]   [Full Text] [Related]  

  • 19. Extended HBV vaccination in liver transplant recipients for HBV-related cirrhosis: report of two successful cases.
    Di Paolo D; Lenci I; Trinito MO; Tisone G; Angelico M
    Dig Liver Dis; 2005 Oct; 37(10):793-8. PubMed ID: 16024302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.